Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/1998
11/14/1998CA2205076A1 Episomal expression cassettes for gene therapy
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050565A1 Enhanced adenovirus-assisted transfection composition and method
11/12/1998WO1998050542A1 Uncoupling protein homologue: ucp 3
11/12/1998WO1998050079A2 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
11/12/1998WO1998050073A1 Integrin ligand, human mindin
11/12/1998WO1998050067A2 Use or a secretion vector for fertility control by oral vaccination
11/12/1998WO1998050061A1 Novel therapies for cystic kidney disease
11/12/1998WO1998050053A1 Gene transfer with adenoviruses having modified fiber proteins
11/12/1998WO1998036061A3 Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity
11/12/1998WO1998032846A3 Enzymatic nucleic acid treatment of diseases or conditions related to levels of c-fos
11/12/1998WO1998032457A3 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/12/1998WO1997039128A3 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
11/12/1998DE19720761A1 Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung Process for the synthesis and secretion of contraceptive suitable proteins or protein fragments by attenuated salmonella or other gram-negative attenuated vaccine strain to produce an oral vaccination
11/12/1998CA2289215A1 Gene transfer with adenoviruses having modified fiber proteins
11/12/1998CA2288901A1 Uncoupling protein homologue: ucp 3
11/12/1998CA2288602A1 Use of a secretion vector for fertility control by oral vaccination
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877030A2 EPO primary response gene 1,(EPRG1)
11/11/1998EP0876507A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2C$g(a) - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION
11/11/1998EP0876492A1 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells
11/11/1998EP0876491A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK
11/11/1998EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
11/11/1998EP0876484A1 Recombinant expression of proteins from secretory cell lines
11/11/1998EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor
11/11/1998EP0876482A1 Il-13 receptor polypeptide
11/11/1998EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application
11/11/1998EP0766570A4 Methods for treating respiratory disease
11/11/1998CN1198676A Glucocorticold ehancement of gene expression
11/11/1998CN1198675A Medicine comprising HGF gene
11/10/1998US5834589 Chimeric viral receptor polypeptides
11/10/1998US5834587 G-protein coupled receptor, HLTEX 11
11/10/1998US5834441 Introducing a genetic sequence into a host cell
11/10/1998US5834440 Administering to human muscle cell an effective amount of dna to favor transcription of the dna to produce ribozyme
11/10/1998US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors
11/10/1998US5834306 Tissue specific hypoxia regulated therapeutic constructs
11/10/1998US5834298 Antitumor agents
11/10/1998US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus
11/10/1998US5834266 Regulated apoptosis
11/10/1998US5834256 Novel retroviral packaging system, transfection in human cells
11/10/1998US5834248 Treatment and diagnosis of cardiovascular disease
11/10/1998US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders
11/10/1998US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998US5834186 Regulatable RNA molecule
11/10/1998US5834179 Morphogenic protein compositions of matter
11/10/1998US5834001 Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core
11/10/1998US5833991 A glycine-rich amino acid sequence is inserted into a fusion protein to prevent an immunogenic response; gene therapy; transfer vectors; vaccines
11/10/1998US5833981 Human phosphorylase kinase gamma subunit
11/10/1998US5833979 Methods and compositions of growth control for cells encapsulated within bioartificial organs
11/10/1998US5833978 Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of recessive myopathies like muscular dystrophy, for improving transplantation success
11/10/1998US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049560A1 Cadherin-11 as an indicator of viable pregnancy
11/05/1998WO1998049350A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998WO1998049349A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES
11/05/1998WO1998049348A1 Oligonucleotides for enhanced bioavailability
11/05/1998WO1998049336A1 Metastasis models using green fluorescent protein (gfp) as a marker
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049333A2 Eukaryotic gene expression cassette and uses thereof
11/05/1998WO1998049322A1 Neurotrypsin
11/05/1998WO1998049321A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998WO1998049311A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
11/05/1998WO1998049300A2 Truncated vegf-related proteins
11/05/1998WO1998049299A1 Leukemia associated genes
11/05/1998WO1998049292A2 Polypeptides associated with activator receptors and their biological applications
11/05/1998WO1998049291A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
11/05/1998WO1998049290A2 Syndecan interacting proteins and the use thereof
11/05/1998WO1998049288A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection
11/05/1998WO1998049265A1 Regulators of ucp2 gene expression
11/05/1998WO1998049188A1 Inhibitors of the jnk signal transduction pathway and methods of use
11/05/1998WO1998048842A1 Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes
11/05/1998WO1998048841A1 Use of papovavirus capsid protein for delivery of genetic material
11/05/1998WO1998048835A1 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
11/05/1998WO1998048830A1 Method for promoting myogenesis using osteogenic proteins
11/05/1998WO1998048829A1 A vertebrate lens obtained from an ectodermal cell and methods of use thereof
11/05/1998WO1998048821A2 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998WO1998048785A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998WO1998048780A1 Vesicular complexes and methods of making and using the same
11/05/1998WO1998048626A1 Methods and compositions for administering dna to mucosal surfaces
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998037091A3 Modified retinoblastoma tumor suppressor proteins
11/05/1998WO1998033527A3 Cancer immunotherapy with semi-allogeneic cells
11/05/1998WO1998031799A3 Polynucleotides and polypeptides encoding receptors
11/05/1998DE19720152A1 Retroviral vector system for gene therapy
11/05/1998CA2289454A1 Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
11/05/1998CA2289253A1 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
11/05/1998CA2288990A1 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998CA2288346A1 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998CA2288306A1 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998CA2288209A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998CA2287916A1 Polypeptides associated with activator receptors and their biological applications
11/05/1998CA2287906A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptotic cell death pathways
11/05/1998CA2287538A1 Truncated vegf-related proteins
11/05/1998CA2286894A1 Regulators of ucp2 gene expression
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
1 ... 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 ... 870